RA Capital Nexus Fund IV, L.P.

CIK 2053586
Transactions on file
9
Open-market buys
6
Win rate (buys)
100%
6 scored
Avg % since filing (buys)
+103.4%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-05-062026-05-06COAG
Hemab Therapeutics Holdings, Inc.
Director
Buy53,407$1.33M+79.3%open →
2026-05-062026-05-06COAG
Hemab Therapeutics Holdings, Inc.
Director
Buy14,611$347.3K+87.3%open →
2026-05-062026-05-05COAG
Hemab Therapeutics Holdings, Inc.
Director
Buy10,268$256.7K+78.1%open →
2026-05-062026-05-05COAG
Hemab Therapeutics Holdings, Inc.
Director
Buy87,143$2.14M+81.1%open →
2026-05-062026-05-04COAG
Hemab Therapeutics Holdings, Inc.
Director
Buy133,750$2.41M+147.4%open →
2026-05-062026-05-04COAG
Hemab Therapeutics Holdings, Inc.
Director
Buy2,541,250$45.74M+147.4%open →
2026-05-062026-05-04COAG
Hemab Therapeutics Holdings, Inc.
Director
C221,188$0.00open →
2026-05-062026-05-04COAG
Hemab Therapeutics Holdings, Inc.
Director
C1,009,052$0.00open →
2026-05-062026-05-04COAG
Hemab Therapeutics Holdings, Inc.
Director
C3,607,846$0.00open →